## **Core Concept**
Mephentermine is a medication used in the management of hypotension, particularly in cases of hypovolemic shock. It belongs to the class of drugs known as indirect-acting sympathomimetic amines. Its primary mechanism involves the release of norepinephrine from nerve terminals.

## **Why the Correct Answer is Right**
The correct answer, **D. release of norepinephrine from nerve terminals**, highlights mephentermine's mechanism of action. Mephentermine acts by stimulating the release of norepinephrine from the nerve terminals of the sympathetic nervous system. This increase in norepinephrine levels leads to vasoconstriction, which helps to increase blood pressure in cases of hypotension or shock. This action is beneficial in the short-term management of hypovolemic shock when intravenous fluid supplementation is not immediately available or as an adjunct to fluid therapy.

## **Why Each Wrong Option is Incorrect**
- **Option A: Direct stimulation of β1 receptors** - This is incorrect because mephentermine's primary action is not through direct stimulation of β1 receptors but through the release of norepinephrine.
- **Option B: Blockade of α2 receptors** - This is incorrect because mephentermine does not act by blocking α2 receptors; its action is related to the release of norepinephrine.
- **Option C: Inhibition of phosphodiesterase** - This is incorrect as mephentermine's mechanism does not involve the inhibition of phosphodiesterase, which is a mechanism associated with some other types of drugs that increase cyclic AMP levels.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that while mephentermine can be used in the management of hypotension due to hypovolemic shock, it is not a substitute for fluid resuscitation. Fluid replacement is always the primary treatment for hypovolemic shock, and vasopressors like mephentermine are used as adjunctive therapy to support blood pressure.

## **Correct Answer: D. release of norepinephrine from nerve terminals**